USPTO serial 79322850
Serial No. 79322850
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 31, 2023
- Examiner
- FENNESSY, EDWARD JOHN
- Law office
- TMEG LAW OFFICE 101
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79322850?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cheryl L. Burbach
Cheryl L. Burbach Erise IP, P.A.7015 College Blvd.Suite 700Overland Park, KS 66211Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; Biochemical preparations for scientific purposes; Biological preparations for use in industry and science; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Biochemicals, namely, polypeptides for in vitro research use; Enzymes for scientific and research purposes; Nucleotides for scientific and research use; Buffer solutions for use in analytical chemistry | ACTIVE | — |
| 005 | Diagnostic preparations for medical purposes; Diagnostic preparations for medical and veterinary use; Preparations of microbial extracts, assays, genes, proteins and enzymes for testing of body fluids; Biological and biochemical reagents for medical use; Diagnostic medical reagents for medical use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases and cancer, comprised of medical diagnostic reagents and diagnostic test patches; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing | ACTIVE | — |
| 009 | Diagnostic apparatus for the detection of pathogens for laboratory or research use; Diagnostic apparatus for testing food; Probes for scientific purposes; Medical laboratory research instruments for testing and analyzing biological substances for the presence, absence or quantity of target chemicals; Downloadable computer software for use in analysing and managing biological data; Downloadable computer programs for use in spectral analysis; Downloadable computer programs for use in controlling affinity capture optical biosensors; Downloadable computer programs for use in chromatography data analysis; Downloadable computer programs for use in the detection, identification and characterization of proteins and processing of spectrometer data; Downloadable computer software for scientific analysis of genetic sequences; Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; Laboratory equipment, namely, microarrays | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Carterra, Inc.
- Other trademarks owned by FOx Biosystems N.V.
- Other trademarks owned by FOx Biosystems N.V.
- Other trademarks owned by FOx Biosystems N.V.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 22, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 22, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 22, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 22, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 22, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 29, 2025 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Mar 28, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 30, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 4, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 4, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 30, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 31, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 31, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 15, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 15, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 26, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 13, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 24, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 24, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 24, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 28, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 8, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 8, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 5, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 4, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 19, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 15, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 14, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |